Effect of Dipeptidyl Peptidase-4 inhibitors combined with Acarbose on blood glucose control and body mass index of elderly patients with type 2 diabetes mellitus
LI Yi1 CHANG Hai-ying2
1.Department of Endocrinology,People′s Hospital of Ganzhou City in Jiangxi Province,Ganzhou 341000,China;2.The First Department of Intracardiac Medicine,the First Affiliated Hospital of Gannan Medical College,Jiangxi Province,Ganzhou 341000,China
Abstract：Objective To investigate the clinical efficacy of dipeptidyl peptidase-4 inhibitors combined with acarbose in the treatment of elderly patients with type 2 diabetes mellitus （T2DM）.Methods A total of 108 cases of T2DM patients in our hospital from September 2015 to October 2017 were selected,and divided into the observation group and the control group according to the random number table method,with 54 cases in each group.On the basis of routine diet and exercise intervention,the control group was treated with acarbose,and the observation group was treated with acarbose+dipeptidyl peptidase-4 inhibitors (sitagliptin).Both groups were treated for 12 weeks.The blood glucose level[fasting blood glucose(FBG),postprandial 2 h blood glucose(2h PG),glycosylated hemoglobin(HbA1c)],body mass index (BMI)and incidence of adverse reactions during treatment were compared between the two groups before and after treatment.Results After treatment,the levels of FBG,2 h PG and HbA1c were lower than those before treatment in two groups(P<0.05),and the observation group was lower than the control group(P<0.05).After treatment,the BMI in the observation group was lower than that before the treatment(P<0.05),but there were no significant changes in the control group(P>0.05),and the BMI in the observation group was lower than that in the control group(P<0.05).There were no significant differences in the incidence of flatulence,diarrhea and nasopharyngitis in the observation group compared with the control group during the treatment(P>0.05).Conclusion Dipeptidyl peptidase-4 inhibitors combined with acarbose in the treatment of elderly T2DM is beneficial to the control of blood sugar and the decrease of BMI,and it has high safety.
李毅;常海英. 二肽基肽酶-4抑制剂联合阿卡波糖对老年2型糖尿病患者血糖控制及体重指数的影响[J]. 中国当代医药, 2018, 25(26): 66-68.
LI Yi;CHANG Hai-ying. Effect of Dipeptidyl Peptidase-4 inhibitors combined with Acarbose on blood glucose control and body mass index of elderly patients with type 2 diabetes mellitus. 中国当代医药, 2018, 25(26): 66-68.
京公网安备 11010502046607号